Skip to main content
. Author manuscript; available in PMC: 2021 Jul 12.
Published in final edited form as: Clin Microbiol Infect. 2018 Apr 21;25(2):210–216. doi: 10.1016/j.cmi.2018.04.012

Table 3.

Adverse events

Adverse event Carrageenan
(n = 141)
Placebo
(n = 139)
pa
Any 62 (44.0%) 43 (30.9%) 0.02
Unusually painful or heavy period 0 3 (2.2%) 0.08
Vaginal bleeding in between menstrual periods 3 (2.1%) 4 (2.9%) 0.69
Pain during vaginal sex 8 (5.7%) 2 (1.4%) 0.06
Unusual vaginal discharge 8 (5.7%) 2 (1.4%) 0.06
Itching, burning or pain in genital area 16 (11.3%) 11 (7.9%) 0.33
Genital sore/ulcer 1 (0.7%) 2 (1.4%) 0.55
Needing to urinate more often than usual 1 (0.7%) 3 (2.2%) 0.31
Pain while urinating 4 (2.8%) 1 (0.7%) 0.18
Blood in urine 3 (2.1%) 1 (0.7%) 0.32
Lower abdominal pain 2 (1.4%) 0 0.16
Lower back pain 0 0
Other 16 (11.3%) 14 (10.1%) 0.73
a

By z test.